Five Prime Therapeutics buy Rathjen
Start price
23.04.17
/
50%
€30.08
Target price
07.11.17
€45.10
Performance (%)
-25.76%
End price
07.11.17
€22.33
Summary
This prediction ended on 07.11.17 with a price of €22.33. The prediction for Five Prime Therapeutics disappointed with a performance of -25.76%. Rathjen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Five Prime Therapeutics | - | - | - | - |
| iShares Core DAX® | 1.085% | -1.655% | 13.297% | 57.692% |
| iShares Nasdaq 100 | -1.665% | -3.137% | 2.218% | 83.804% |
| iShares Nikkei 225® | 3.863% | 6.947% | 22.818% | 56.282% |
| iShares S&P 500 | 0.111% | -1.320% | 1.445% | 57.791% |
Comments by Rathjen for this prediction
In the thread Five Prime Therapeutics diskutieren
Gute Einstiegschance
Hier könnte charttechnisch ein Boden gefunden werden.
Stopp bei 25,- $
s. a.
https://www.godmode-trader.de/analyse/bb-biotech-q1-zahlen-depot-umschichtungen-die-charttechnik,5269984
(Stop Loss Kurs erreicht)